Short answer
Harmony Biosciences Holdings, Inc. (HRMY) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings reported Feb 24, 2026: see Exhibit 99.1 for detailed financials.
Harmony Biosciences Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings reported Feb 24, 2026: see Exhibit 99.1 for detailed financials
- Results cover quarter and year ended Dec 31, 2025
Item 7.01 · Regulation FD Disclosure
- Harmony Biosciences posted an investor presentation on Feb 24, 2026 to its IR website for use in analyst/investor meetings
- Presentation is "furnished" not "filed": not subject to Exchange Act Section 18 liability, limiting investor recourse
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Harmony Biosciences Holdings, Inc. 8-K filings
Get the next HRMY 8-K as it lands
Follow HRMY for push alerts, or ask the research agent what this filing means.